Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present Nicox S.A. (OTC: NICXF).

Full DD Report for NICXF

You must become a subscriber to view this report.


Recent News from (OTC: NICXF)

Nicox reports Q3 results
Nicox ( OTCPK:NICXF ): Q3 Revenue of $0.44M More news on: NICOX SA EUR ORD NEW, Earnings news and commentary, Healthcare stocks news, , Read more ...
Source: SeekingAlpha
Date: October, 17 2018 02:47
FDA OKs Sun Pharma's Xelpros for lowering IOP in glaucoma patients
The FDA approves Sun Pharmaceuticals' ( OTCPK:SMPQY ) XELPROS (latanoprost ophthalmic emulsion) 0.005% for reducing elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension. More news on: Sun Pharmaceuticals Industries Ltd. ADR, Aerie Pharmaceuticals, Inc...
Source: SeekingAlpha
Date: September, 14 2018 07:21
Nicox reports 1H results
Nicox ( OTCPK:NICXF ): 1H net loss of €7.6M More news on: NICOX SA EUR ORD NEW, Earnings news and commentary, Healthcare stocks news, , Read more ...
Source: SeekingAlpha
Date: September, 06 2018 01:58
3 Things In Biotech, August 3: Bristol Assaults Melanoma In Europe Again
Welcome to another edition of "3 Things In Biotech," a daily digest dedicated to helping you keep pace with the fast-moving world of pharmaceutical and biotechnology research. Bristol-Myers marches on in European melanoma care Company: Bristol-Myers Squibb ( BMY ) Therapy: Nivolumab Di...
Source: SeekingAlpha
Date: August, 03 2018 08:00
Nicox (NICXF) Presents At European Biotech Investor Day In NYC - Slideshow
The following slide deck was published by NICOX SA EUR ORD NEW in conjunction with this Read more ...
Source: SeekingAlpha
Date: July, 20 2018 13:32
Nicox reports Q2 results
Nicox ( OTCPK:NICXF ): Q2 Revenue of €0.26M More news on: NICOX SA EUR ORD NEW, Earnings news and commentary, Healthcare stocks news, , Read more ...
Source: SeekingAlpha
Date: July, 17 2018 05:40
Nicox reports Q1 results
Nicox ( OTCPK:NICXF ): Q1 Revenue of €0.075M More news on: NICOX SA EUR ORD NEW, Earnings news and commentary, Healthcare stocks news, , Read more ...
Source: SeekingAlpha
Date: May, 04 2018 03:45
Nicox (NICXF) Presents At Ophthalmology Innovation Summit - Slideshow
The following slide deck was published by NICOX SA EUR ORD NEW in conjunction with this Read more ...
Source: SeekingAlpha
Date: April, 13 2018 13:26
Nicox (NICXF) Presents At H. C. Wainwright Global Life Sciences Conference - Slideshow
The following slide deck was published by NICOX SA EUR ORD NEW in conjunction with this Read more ...
Source: SeekingAlpha
Date: April, 11 2018 14:14
pSivida and Nicox inks deal to develop sustained release drug to lower IOP in patients with Glaucoma; shares ahead 12% premarket
pSivida (NASDAQ: PSDV ) and Nicox S.A. ( OTCPK:NICXF ) collaborate  to explore the potential of combining pSivida's bioerodible sustained release drug delivery system with Nicox's nitric oxide-donating compounds, to develop a sustained release drug to lower intraocular pressure in pati...
Source: SeekingAlpha
Date: October, 10 2017 07:48

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-12-14N/A5.235N/AN/A0
2018-12-13N/A5.235N/AN/A0
2018-12-125.2355.2355.2355.235440
2018-12-11N/A5.10N/AN/A0
2018-12-105.105.105.105.10100

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-12-10100100100.0000Short
2018-11-28100100100.0000Short
2018-11-27640640100.0000Short
2018-11-16100100100.0000Short
2018-10-24300300100.0000Short

* Short Mode

Short Analysis provided by Squeeze Report. Get a complete short report on NICXF.


About Nicox S.A. (OTC: NICXF)

Logo for Nicox S.A. (OTC: NICXF)

Not available

 

Contact Information

 

 

Current Management

  • Michele Garufi / CEO
  • Eric Castaldi / CFO
  • Elizabeth Robinson / EVP, Dev.
  • Piero Del Soldato / EVP
  • Pascal Pfister / CSO
  • Michele Garufi / Chairman

Current Share Structure

     



    Daily Technical Chart for (OTC: NICXF)

    Daily Technical Chart for (OTC: NICXF)


    Stay tuned for daily updates and more on (OTC: NICXF)

    It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

    More to come on (OTC: NICXF)

    Do your DD and if you choose, be ready to go!


     

    The Research: All source information contained in this email is from the public sources mentioned below.

     

     
     

    Thank you

    DD Report
    @DDReports

     

     


    Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in NICXF is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received no compensation for the publication and circulation of this report. DD Report does not own any shares of NICXF and does not buy, sell, or trade any shares of NICXF. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: https://dd.report/disclaimer/